Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder.

@article{Escobar2009EvaluationOP,
  title={Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder.},
  author={Rodrigo Escobar and A. P. Montoya and Pepa Polavieja and Esther Cardo and Josep Artigas and Amaia Herv{\'a}s and Joaqu{\'i}n Fuentes},
  journal={Journal of child and adolescent psychopharmacology},
  year={2009},
  volume={19 3},
  pages={253-63}
}
OBJECTIVE The aim of this study was to demonstrate the superior efficacy of atomoxetine with respect to placebo and to compare parent and child perceptions of health-related quality of life (HRQoL). METHOD This randomized, placebo-controlled, 12-week parallel clinical trial included 151 untreated children/adolescents with newly diagnosed attention-deficit/hyperactivity disorder (ADHD). Parents' and patients' reports of HRQoL were obtained separately using the Child Health and Illness Profile… CONTINUE READING